Clinical Trials Logo

Clinical Depression clinical trials

View clinical trials related to Clinical Depression.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05685758 Completed - Depression Clinical Trials

A Treatment for Depression Via a Gamified Mobile Phone Application Based on a New Cognitive Model

FTP
Start date: November 3, 2022
Phase: N/A
Study type: Interventional

The study is a randomized controlled treatment study comparing changes in depressive symptoms over 8 weeks between individuals with Major Depressive Disorder (MDD) who have access to an FTP-based mobile phone application and a control group not engaging with the app. FTP, the process of Facilitating Thought Progression, trains the brain's cognitive thought process to expand, accelerate, and be more creative, to alleviate depressive symptoms.

NCT ID: NCT03489304 Completed - HIV/AIDS Clinical Trials

Zaleplon in HIV Patients With Depression

Start date: April 3, 2014
Phase: Phase 2
Study type: Interventional

In HIV positive patients with sleep onset insomnia and receiving pharmacologic treatment for comorbid depression, the proposed study aims to evaluate the impact of zaleplon on sleep measures determined by insomnia severity index (ISI) and Epworth sleepiness scale (ESS).

NCT ID: NCT03237221 Completed - Asthma Clinical Trials

Clinical Characteristics, Treatment and Prognosis of Chest Tightness Variant Asthma

Start date: March 1, 2015
Phase:
Study type: Observational

Asthma, abbreviation for bronchial asthma, is one of the common chronic airways disease that threatens human health. Typical symptoms of asthma are recurrent wheezing, shortness of breath, chest tightness and cough, usually occurring at night or early morning. However, there are still some patients with only persistent clinical manifestations of chest tightness. Concerned about this group of patients, we presented a subgroup of bronchial asthma, namely, chest tightness variant asthma (CTVA). This asthma subgroup usually lacks asthma-specific clinical features such as wheezing, shortness of breath, wheezing, and therefore often misdiagnosed for a long time. In order to further understand the clinical characteristics, pathogenesis, and prognosis of patients with CTVA, we conducted a national multicenter observation study to further understand CTVA. Finally, we plan to clarify whether CTVA is a relatively independent asthma phenotype. Meanwhile, reducing misdiagnosis and perform an appropriate treatment of CTVA.

NCT ID: NCT01977326 Completed - Clinical trials for Postpartum Depression

Task Sharing Counseling Intervention by Community Health Workers for Prenatal Depression in South Africa

AFFIRM-SA
Start date: October 2013
Phase: N/A
Study type: Interventional

The objective of this randomised controlled trial (RCT) is to determine the effectiveness and cost-effectiveness of a task sharing counseling intervention for maternal depression in South Africa(i.e. provided by non-specialist health workers)

NCT ID: NCT01763216 Completed - Depressive Symptoms Clinical Trials

Improving Mood in Assisted Living Settings

Start date: February 2013
Phase: N/A
Study type: Interventional

Late-life depression levels are escalating, and include 24% of all tenants of Assisted Living (AL) settings. A promising, novel intervention is a computerized visual speed of processing training program known as Road Tour. Road Tour has been show to reduce depressive symptom levels and the risk of onset of clinical depression in community dwelling older adults. The investigators hypothesize that similar benefits will accrue to residents in AL settings. To evaluate this the investigators will use a two-arm, parallel, randomized controlled trial (RCT) comparing Road Tour training to attention control using computerized crossword puzzles among 370 adults 55 years old or older who reside in 15-30 AL settings that are partnering with the investigators. The investigators hypothesize that Road Tour participants will have improved cognitive processing speed, lower levels of depressive symptoms, lower likelihood of the onset of clinical depression, less anxiety, lower levels of pain symptoms, and better health-related quality of life. These outcomes will be assessed at baseline, post-training, six months, and one year.